Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 126.50
-0.50 (-0.39%)
Oct 4, 2024, 5:29 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 53.20M SEK in the quarter ending June 30, 2024, with 41.11% growth. This brings the company's revenue in the last twelve months to 196.10M, up 37.61% year-over-year. In the year 2023, Devyser Diagnostics AB had annual revenue of 169.30M with 33.73% growth.
Revenue (ttm)
196.10M
Revenue Growth
+37.61%
P/S Ratio
10.49
Revenue / Employee
1.54M
Employees
118
Market Cap
2.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.17B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |